Astrana Health Reports Record Q3 Revenue and Projects Mid-Teens EBITDA Growth Through 2027
Astrana Health (ASTH) reported a record third quarter with revenue reaching $1.02 billion, driven by margin expansion and disciplined operational execution. CEO Brandon Sim highlighted the company's strong performance as it continues to scale its healthcare services model. Looking ahead, the company provided long-term guidance projecting adjusted EBITDA growth in the mid-teens through 2027. However, management also forecasted a potential 10% to 15% decline in Medicaid membership, signaling a shift in their member composition and strategic focus.
Tickers: $ASTH